Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting Sara Marsal Barril; Mª Auxiliadora Martin-Martinez; Francisco Javier Blanco-Garcia; Antonio Fernández-Nebro; Rosario García de Vicuña; Jesús Tornero-Molina; Fernando Sánchez-Alonso; Marta Novella-Navarro; Alejandro Escudero-Contreras; Juan José Alegre-Sancho; Ana Urruticoechea-Arana; Maria Sagrario Bustabad-Reyes; Pilar Trenor-Larraz; Trinidad Pérez-Sandoval; Maria Isabel Tevar-Sánchez; Jesús T. Sánchez-Costa; Enrique Raya-Álvarez;

Cost evolution of biological drugs in rheumatoid arthritis patients in a tertiary hospital: Influential factors on price Mariángeles González Fernández; Elena Villamañán; Inmaculada Jiménez-Nácher; Francisco Moreno; Chamaida Plasencia; Francisco Gayá; Alicia Herrero; Alejandro Balsa;

Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018 Mario H. Cardiel; Sandra Carrillo; Marcela Pérez; Lilia Andrade; César Pacheco Tena; Luis H. Silveira; Leonardo Limón; Sergio Cerpa; Sergio Gutiérrez Ureña; Sergio Durán; Fedra Irazoque Palazuelos; Sandra Muñoz López; Sandra Araceli Sicsik Ayala; Leonor Barile; María Azucena Ramos Sánchez; Daniel Grajeda Portes; Margarita Portela; Alina Hernández Bedolla; José Luis García-Figueroa; Mauricio Montero; Carlos Abud-Mendoza; Marco Ulises Martínez Martínez; David Herrera van Ostdam; Virginia Pascual-Ramos; Javier Merayo-Chalico; Istar Guzmán-Sánchez; María Esther Pérez-Bastidas; Jorge Enrique Aguilar Arreola; Alejandra López Rodríguez; Greta Reyes-Cordero; Humberto Alfredo Ricardez; María Fernanda Hernández Cabrera; Guadalupe Olvera-Soto; Daniel Xibillé Friedmann;